Your browser doesn't support javascript.
loading
Use of Prothrombin Complex Concentrate in Oral Anticoagulant-Associated Major Bleeding.
Lukas, Jack G; Reichert, Michael J; Jones, G Morgan.
Afiliación
  • Lukas JG; Department of Pharmacy, Methodist University Hospital, Memphis, Tennessee (Drs Lukas, Reichert, and Jones); and College of Pharmacy (Drs Lukas, Reichert, and Jones) and College of Medicine (Dr Jones), University of Tennessee Health Science Center, Memphis.
Crit Care Nurs Q ; 45(2): 167-179, 2022.
Article en En | MEDLINE | ID: mdl-35212656
Severe bleeding remains the most significant adverse effect associated with both warfarin and the direct oral anticoagulant agents. Due to the life-threatening nature of these bleeds, knowledge and understanding of agents that are able to rapidly overcome the anticoagulation effects of these medications is paramount to their use. Worldwide, the most commonly used agent for this indication is prothrombin complex concentrate (PCC). This review summarizes the evidence on the use of PCC in this population and provides practical information regarding patient-specific administration considerations.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factores de Coagulación Sanguínea / Anticoagulantes Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Crit Care Nurs Q Asunto de la revista: ENFERMAGEM / TERAPIA INTENSIVA Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factores de Coagulación Sanguínea / Anticoagulantes Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Crit Care Nurs Q Asunto de la revista: ENFERMAGEM / TERAPIA INTENSIVA Año: 2022 Tipo del documento: Article